Medadvisor Ltd
ASX:MDR
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.185
0.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Medadvisor Ltd
Medadvisor Ltd
Revenue
Medadvisor Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medadvisor Ltd
ASX:MDR
|
Revenue
AU$122.1m
|
CAGR 3-Years
45%
|
CAGR 5-Years
68%
|
CAGR 10-Years
130%
|
|
|
4DMedical Ltd
ASX:4DX
|
Revenue
AU$3.8m
|
CAGR 3-Years
159%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Revenue
$43.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Revenue
AU$166.3m
|
CAGR 3-Years
35%
|
CAGR 5-Years
27%
|
CAGR 10-Years
28%
|
|
|
Medibio Ltd
ASX:MEB
|
Revenue
AU$963.8k
|
CAGR 3-Years
1%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Revenue
AU$37.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
76%
|
|
Medadvisor Ltd
Glance View
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
See Also
What is Medadvisor Ltd's Revenue?
Revenue
122.1m
AUD
Based on the financial report for Jun 30, 2024, Medadvisor Ltd's Revenue amounts to 122.1m AUD.
What is Medadvisor Ltd's Revenue growth rate?
Revenue CAGR 10Y
130%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Medadvisor Ltd have been 45% over the past three years , 68% over the past five years , and 130% over the past ten years .
You don't have any saved screeners yet
